We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund

79 hedge funds and large institutions have $541M invested in First Trust NYSE Arca Biotechnology Index Fund in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 4

112% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 17

103% more call options, than puts

Call options by funds: $4.11M | Put options by funds: $2.03M

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

23% more funds holding

Funds holding: 6479 (+15)

22% more capital invested

Capital invested by funds: $445M → $541M (+$95.9M)

1.35% more ownership

Funds ownership: 54.27%55.61% (+1.3%)

Holders
79
Holders Change
+15
Holders Change %
+23.44%
% of All Funds
2.29%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
20
Increased
36
Reduced
17
Closed
4
Calls
$4.11M
Puts
$2.03M
Net Calls
+$2.08M
Net Calls Change
+$1.27M

FBT Hedge Fund Activity: Q4 2013 in Review

79 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q4 2013, worth a combined $541M — up 22% from $445M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new FBT positions and 4 closed out — a net gain of 16 holders — while 36 added to existing stakes and 17 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $16.9M. The largest seller was Stadion Money Management, exiting entirely with an estimated $2.77M sold.

  • 79 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q4 2013, up from 64 in Q3 2013.
  • Funds reported $541M of First Trust NYSE Arca Biotechnology Index Fund stock for Q4 2013, up 22% quarter-over-quarter.
  • 20 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q4 2013 and 4 closed out, a net change of +16 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q4 2013 was Morgan Stanley, an estimated $16.9M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q4 2013 was Stadion Money Management, an estimated $2.77M sold.

Based on aggregated 13F filings for Q4 2013.